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Abstract. A total of 100 Actinobacillus pleuropneumoniae strains isolated from 
Hungary and Romania were tested for in vitro susceptibility to 7 antimicrobial agents by 
using standard disc diffusion method. Results showed that majority of A. pleuropneumoniae 
isolates were found susceptible to most antimicrobial agents tested. 
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INTRODUCTION 
 
Actinobacillus pleuropneumoniae is the causative agent of porcine pleuropneumonia, a 
highly contagious swine disease, causing severe production losses in some countries (Bosse et 
al., 2002; Zutic et al, 2008). Although proper management, sanitation, nutrition, and 
vaccination are generally useful in preventing A. pleuropneumoniae infections, use of 
antibiotics for treatment of infected pigs is necessary to avoid economic losses. However, 
application of antibiotics in the treatment of pig’s pleuropneumonia may lead to selective 
survival of drug resistant strains (Wang et al. 2010). Variations in antimicrobial use for the 
control of A. pleuropneumoniae infections from one country to another and variations in 
methodology can contribute to evident differences in antimicrobial susceptibility of A. 
pleuropneumoniae (Kucerova et al. 2011). 
 
MATERIALS AND METHODS 
 
 A total of 100 A. pleuropneumoniae strains, isolated between 2008 and 2011 from the 
lungs of diseased pigs from herds located in Hungary and Romania, were included in this 
study. The study was performed at the Diagnostic Laboratory of the Large Animal Clinic, 
Faculty of Veterinary Science, Szent István University, Üllı, Hungary.  
The strains were isolated on blood agar plates, using V factor discs (Difco). 
Identification of the strains as A. pleuropneumoniae was based on Gram-stain, hemolysis on 
5% sheep blood agar, positive Christie-Atkins-Munch-Petersen (CAMP) reaction, 
requirement for NAD and urease production. Strains wore stored at -80ºC and were thawn and 
striked on blood agar prior to use. 
Antimicrobial susceptibility of A. pleuropneumoniae isolates was tested by the disc 
diffusion test in Petri dishes containing Haemophillus test medium base (HTM) with HTM 
supplement (OXOID) following the recommendations of Clinical and Laboratory Standards 
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Institute M31-A3 (CLSI, 2008). HTM is a medium specifically formulated for the 
susceptibility testing of fastidious organisms containing Mueller Hinton agar and yeast extract 
- specifically selected for low antagonist levels. The results achieved using HTM have been 
found to be highly reproducible. The transparency of the medium allows zones of inhibition 
to be read easily through the bottom of the Petri dish. HTM contains low levels of 
antimicrobial antagonists, which allows testing of trimethoprim/sulphamethoxazole to be 
carried out with greater confidence. HTM supplement contains NAD and haematin.   
The following seven antimicrobial agents, commonly recommended and administered 
to treat pleuropneumonia in pigs, were tested: amoxicillin (AX-25 µg), enrofloxacin (ENR-5 
µg), tiamulin (TIA-30 µg), trimethoprim/sulphamethoxazole (SXT-25 µg), tilmicosin (TIL-15 
µg), florfenicol (FFC-30 µg), doxycycline (DO-30 µg). Tests were done with commercially 
available discs (Biolab, Hungary; Oxoid, UK). 
The density of direct colony suspension was adjusted to 0.5 McFarland standard (1 to 
2 × 108 CFU/ml) and plates were inoculated by spilling the suspension over the surface. The 
appropriate drug-impregnated discs were placed individually on the dry surface of the plates 
within 15 minutes after inoculation, allowing for any excess surface moisture to be absorbed. 
Inhibition zones were read after 20–24 hours of incubation at 37ºC, results were evaluated 
according to CLSI M31-A3 (2008). 
 
RESULTS AND DISCUSSION 
 
Table 1 presents disc diffusion susceptibility test results of 100 A. pleuropneumoniae 
isolates to 7 antimicrobial agents. 
 
Tab. 1. 
Antimicrobial susceptibility of 100 A. pleuropneumoniae strains 
 
 
 
 
 
 
 
 
 
 
 
 
 
Generally, our 100 A. pleuropneumoniae isolates showed low levels of antimicrobial 
resistance. Out of the tested compounds, tiamulin proved to be the most effective. All A. 
pleuropneumoniae isolates were susceptible to this antimicrobial, which is in accordance with 
previous studies (Aarestrup and Jensen, 1999). The percentage of sensitivity to florfenicol 
was also high, 98% of the tested strains being susceptible and 2% intermediate to this 
amphenicol antibiotic. No resistance was encountered. Regarding β-lactams, 67% of isolates 
were susceptible and only 5% resistant to amoxicillin. Similar results regarding florfenicol 
and amoxicillin were obtained by Pascu (2008), who didn’t detect resistance to florfenicol 
either, 87.5% of the strains being susceptible and 12.5% intermediate to this antibiotic; though 
the resistance to amoxicillin in her study was higher 12.9%.  
Number of tested isolates Antimicrobial 
agent 
Disk 
content 
(µg) S I R 
Tiamulin 30 100 - - 
Florfenicol 30 98 2 - 
Tilmicosin 15 78 17 5 
SXT-TMP 25 76 14 10 
Enrofloxacin 5 73 23 4 
Amoxicillin 25 67 28 5 
Doxycycline 30 56 30 14 
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A higher percentage of resistance was registered to trimethoprim-sulphamethoxazole 
and doxycycline, 10% and 14% respectively. Earlier publications reported higher resistance 
of A. pleuropneumoniae to trimethoprim-sulphamethoxazole (Chang et al., 2002; Zutic et al., 
2008). With regard to macrolides, a low-level resistance to tilmicosin was exhibited by five 
isolates. Only 4% of our isolates were resistant to enrofloxacin, 23% were intermediate and 
73% were susceptible. Similar level of sensitivity to this quinolone has been reported by 
Chang et al. (2002), somewhat higher resistance has been reported by Gutiérrez et al. (1995). 
 
CONCLUSIONS 
 
In this study, most isolates of A. pleuropneumoniae were found susceptible in vitro to 
most antimicrobial agents tested. According to our results, the most effective antimicrobial 
agent was tiamulin.  
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